Disruption of the trypanothione reductase gene of Leishmania decreases its ability to survive oxidative stress in macrophages

Parasitic protozoa belonging to the order Kinetoplastida contain trypanothione as their major thiol. Trypanothione reductase (TR), the enzyme responsible for maintaining trypanothione in its reduced form, is thought to be central to the redox defence systems of trypanosomatids. To investigate further the physiological role of TR in Leishmania, we attempted to create TR‐knockout mutants by gene disruption in L.donovani and L.major strains using the selectable markers neomycin and hygromycin phosphotransferases. TR is likely to be an important gene for parasite survival since all our attempts to obtain a TR null mutant in L.donovani failed. Instead, we obtained mutants with a partial trisomy for the TR locus where, despite the successful disruption of two TR alleles by gene targeting, a third TR copy was generated as a result of genomic rearrangements involving the translocation of a TR‐containing region to a larger chromosome. Mutants of L.donovani and L.major possessing only one wild‐type TR allele express less TR mRNA and have lower TR activity compared with wild‐type cells carrying two copies of the TR gene. Significantly, these mutants show attenuated infectivity with a markedly decreased capacity to survive intracellularly within macrophages, provided that the latter are producing reactive oxygen intermediates.

[1]  B. Chait,et al.  Trypanothione: a novel bis(glutathionyl)spermidine cofactor for glutathione reductase in trypanosomatids. , 1985, Science.

[2]  M. Swartz,et al.  Pyridine nucleotide coenzymes of , 1960 .

[3]  A. Fairlamb,et al.  Purification and characterization of trypanothione reductase from Crithidia fasciculata, a newly discovered member of the family of disulfide-containing flavoprotein reductases. , 1986, Biochemistry.

[4]  W. Rutter,et al.  Tubulin genes are tandemly linked and clustered in the genome of trypanosoma brucei , 1983, Cell.

[5]  S. Beverley,et al.  Plasticity in chromosome number and testing of essential genes in Leishmania by targeting. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[6]  L. Hardy,et al.  PTR1: a reductase mediating salvage of oxidized pteridines and methotrexate resistance in the protozoan parasite Leishmania major. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[7]  M. Ouellette,et al.  Gene disruption of the P-glycoprotein related gene pgpa of Leishmania tarentolae. , 1996, Biochemical and biophysical research communications.

[8]  Alan H. Fairlamb,et al.  Trypanothione reductase from Trypanosoma cruzi , 1987 .

[9]  S. Beverley,et al.  Development of a safe live Leishmania vaccine line by gene replacement. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[10]  A. Fairlamb,et al.  Levels of polyamines, glutathione and glutathione-spermidine conjugates during growth of the insect trypanosomatid Crithidia fasciculata. , 1988, Journal of general microbiology.

[11]  Changes in folate and pterin metabolism after disruption of the Leishmania H locus short chain dehydrogenase gene. , 1994, The Journal of biological chemistry.

[12]  A. Fairlamb,et al.  The structure, organization, and expression of the Leishmania donovani gene encoding trypanothione reductase. , 1994, Molecular and biochemical parasitology.

[13]  M. Ouellette,et al.  Selective killing of Leishmania amastigotes expressing a thymidine kinase suicide gene. , 1997, Experimental parasitology.

[14]  A. Fairlamb,et al.  Phenotype of recombinant Leishmania donovani and Trypanosoma cruzi which over-express trypanothione reductase. Sensitivity towards agents that are thought to induce oxidative stress. , 1993, European journal of biochemistry.

[15]  A. Fairlamb,et al.  Trypanothione Reductase from Leishmania donovani , 1995 .

[16]  A. Fairlamb,et al.  Trypanothione reductase from Leishmania donovani. Purification, characterisation and inhibition by trivalent antimonials. , 1995, European journal of biochemistry.

[17]  M. Ouellette,et al.  Trypanothione overproduction and resistance to antimonials and arsenicals in Leishmania. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[18]  A. Fairlamb,et al.  Metabolism and functions of trypanothione in the Kinetoplastida. , 1992, Annual review of microbiology.

[19]  A. Fairlamb,et al.  Extrachromosomal, homologous expression of trypanothione reductase and its complementary mRNA in Trypanosoma cruzi. , 1996, Nucleic acids research.

[20]  G. Matlashewski,et al.  Developmental gene expression in Leishmania donovani: differential cloning and analysis of an amastigote-stage-specific gene , 1994, Molecular and cellular biology.

[21]  S. Beverley,et al.  Selection against the dihydrofolate reductase-thymidylate synthase (DHFR-TS) locus as a probe of genetic alterations in Leishmania major , 1996, Molecular and cellular biology.

[22]  H. F. Fisher Pyridine Nucleotide Coenzymes , 1984 .

[23]  J. Boothroyd,et al.  Activation of trypanosome surface glycoprotein genes involves a duplication-transposition leading to an altered 3′ end , 1981, Cell.

[24]  M. Ouellette,et al.  Mechanisms of drug resistance in Leishmania. , 1993, Parasitology today.

[25]  A. Fairlamb,et al.  Trypanothione reductase from Trypanosoma cruzi. Purification and characterization of the crystalline enzyme. , 1987, European Journal of Biochemistry.

[26]  G. H. Coombs,et al.  Evidence from disruption of the lmcpb gene array of Leishmania mexicana that cysteine proteinases are virulence factors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[27]  J. Seidman,et al.  Production of homozygous mutant ES cells with a single targeting construct , 1992, Molecular and cellular biology.

[28]  A. Fairlamb Metabolism and Functions of Trypanothione with Special Reference to Leishmaniasis , 1989 .

[29]  M. Ouellette,et al.  A novel antifolate resistance gene on the amplified H circle of Leishmania. , 1992, The EMBO journal.

[30]  R. Krauth-Siegel,et al.  Flavoprotein structure and mechanism. 5. Trypanothione reductase and lipoamide dehydrogenase as targets for a structure-based drug design. , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[31]  A. Fairlamb,et al.  Site-directed mutagenesis of the redox-active cysteines of Trypanosoma cruzi trypanothione reductase. , 1995, European journal of biochemistry.

[32]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[33]  D. Schwartz,et al.  Antigenic variation in trypanosoma brucei analyzed by electrophoretic separation of chromosome-sized DNA molecules , 1984, Cell.

[34]  M. Ouellette,et al.  Homologous recombination between direct repeat sequences yields P-glycoprotein containing amplicons in arsenite resistant Leishmania. , 1993, Nucleic acids research.

[35]  M. Ouellette,et al.  Direct and inverted DNA repeats associated with P‐glycoprotein gene amplification in drug resistant Leishmania. , 1991, EMBO Journal.

[36]  D. Hart Leishmaniasis: The current status and new strategies for control. Proceedings of a NATO Advanced Study Institute on leishmaniasis: The first centenary (1885-1985), new strategies for control, Zakinthos, Greece, 20-27 September 1987. , 1989 .

[37]  A. Fairlamb,et al.  Trypanothione dependent peroxide metabolism in Crithidia fasciculata and Trypanosoma brucei. , 1987, Molecular and biochemical parasitology.

[38]  S. Beverley,et al.  Shuttle cosmid vectors for the trypanosomatid parasite Leishmania. , 1993, Gene.

[39]  M. Ouellette,et al.  Autonomous replication of bacterial DNA plasmid oligomers in Leishmania. , 1994, Molecular and biochemical parasitology.

[40]  R. Brun,et al.  Cultivation and in vitro cloning or procyclic culture forms of Trypanosoma brucei in a semi-defined medium. Short communication. , 1979, Acta tropica.

[41]  N. Reiner,et al.  Stimulus-response coupling in monocytes infected with Leishmania. Attenuation of calcium transients is related to defective agonist-induced accumulation of inositol phosphates. , 1992, Journal of immunology.